At a glance
- Originator NicOx
- Class Antiplatelets; Benzoic acids; Salicylic acids; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 10 Nov 1998 Discontinued-Preclinical for Thrombosis in Italy (Unknown route)
- 10 Nov 1998 Discontinued-Preclinical for Thrombosis in United Kingdom (Unknown route)
- 14 Oct 1998 No-Development-Reported for Thrombosis in Italy (Unknown route)